Tele-nursing practices for breast cancer patients
The Effect of Tele-Nursing Practices Based on Technological Competence Theory on Empowerment and Symptom Management in Breast Cancer Patients
This study tests whether tele-nursing support can help breast cancer patients manage their symptoms and feel more empowered during chemotherapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | Female |
| Sponsor | Ataturk University Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Erzurum, Yakutiye) |
| Trial ID | NCT05998655 on ClinicalTrials.gov |
What this trial studies
This research evaluates the impact of tele-nursing practices based on technological competence theory on empowerment and symptom management in breast cancer patients undergoing chemotherapy. The study involves a randomized controlled double-blind design with 70 participants, divided into an experimental group receiving tele-nursing interventions and a control group. Over approximately 11 weeks, the experimental group will receive training, counseling, and tele-monitoring to enhance their self-management skills and overall empowerment. The study aims to improve the quality of care and life for patients by leveraging technology in nursing practices.
Who should consider this trial
Good fit: Ideal candidates are women diagnosed with stages I, II, or III breast cancer who are literate, capable of using a smartphone, and currently receiving neoadjuvant chemotherapy.
Not a fit: Patients with stage IV breast cancer or those unable to communicate verbally or use a smartphone may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the self-efficacy and quality of life for breast cancer patients during chemotherapy.
How similar studies have performed: While tele-nursing is a growing field, this specific application based on technological competence theory is relatively novel and has not been extensively tested in similar contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Breast cancer I., II. or III. in phase * Without organ metastases * Those who have not been diagnosed with any other cancer other than breast cancer * Literate * Receiving neoadjuvant chemotherapy * Received at least 1 course of chemotherapy * Those who does not have hearing and speech problems that will prevent talking on the phone * Capable of using a smartphone * Does not have any psychiatric problems that reduce the ability to understand * Who volunteered to participate in the research Exclusion Criteria: * With stage 4 breast cancer * Organ metastases * Those who have been diagnosed with a cancer other than breast cancer * iliterate * Cannot communicate verbally * Unable to use a smartphone * No internet connection or online access * Who refused to participate in the research
Where this trial is running
Erzurum, Yakutiye
- Ataturk University — Erzurum, Yakutiye, Turkey (Recruiting)
Study contacts
- Principal investigator: Nisa YAVUZER BAYRAK — Ataturk University
- Study coordinator: Nisa YAVUZER BAYRAK
- Email: nisayavuzer@hotmail.com
- Phone: 5434391147
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.